Selective A(2A) adenosine receptor activation reduces ischemia- reperfusion injury in rat kidney

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Okusa, Mark D ^a   Linden, Joel ^a   Macdonald, Timothy ^a   Huang, Liping ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Acute renal failure; DWH 146 ester; Inflammation; Ischemia; ZM 241385

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; CREATININE; UREA; ADENOSINE RECEPTOR; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG POTENCY; GENE ACTIVATION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UREA BLOOD LEVEL; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; KIDNEY; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; HUMANS; KIDNEY; MALE; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; REPERFUSION INJURY; TRIAZINES; TRIAZOLES;

EID: 0033190943     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.3.f404     Document Type: Article

References (39)

1. 2-receptor agonists on intrarenal blood flow. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F802-F806, 1993.
2. Alkhunaizi, A. M., and R. W. Schrier. Management of acute renal failure: new perspectives. Am. J. Kidney Dis. 28: 315-328, 1996.
3. Arakawa, K., H. Suzuki, M. Naitoh, A. Matsumoto, K. Hayashi, H. Matsuda, A. Ichihara, E. Kubota, and T. Saruta. Role of adenosine in the renal response to contrast medium. Kidney Int. 49: 1199-1206, 1996.
4. Arend, L. J., G. L. Bakris, J. C. Burnett, C. Megerian, and W. S. Spielman. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J. Lab. Clin. Med. 110: 406-411, 1987.
5. Bouma, M. G., F. A. J. M. Van Den Wildenberg, and W. A. Buurman. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 270 (Cell Physiol. 39): C522-C529, 1996.
6. Brooker, G., W. Terasaki, and M. G. Price. Gammaflow: a completely automated radioimmunoassay system. Science 194: 270-276, 1976.
7. 2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J. Immunol. 155: 2579-2596, 1995.
8. Chiao, H., Y. Kohda, P. McLeroy, L. Craig, I. Housini, and R. A. Star. α-Melanocyte-stimulating hormone protects against renal injury after Ischemia in mice and rats. J. Clin. Invest. 99: 1165-1172, 1997.
9. Cronstein, B. N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76: 5-13, 1994.
10. Dinour, D., and M. Brezis. Effects of adenosine on intrarenal oxygenation. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F787-F791, 1991.
11. Erley, C. M., S. H. Duda, S. Schlepckow, J. Koehler, P. E. Huppert, W. L. Strohmaier, A. Bohle, T. Risler, and H. Osswald. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int. 45: 1425-1431, 1994.
12. Feigner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84: 7413-7417, 1987.
13. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251: 888-893, 1989.
14. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J. Pharmacol. Exp. Ther. 280: 301-309, 1997.
15. 2 receptors reverse ischemia-reperfusion lung injury independent of β-receptors. J. Appl. Physiol. 78: 990-996, 1995.
16. Knight, R. J., M. R. Collis, M. S. Yates, and C. J. Bowmer. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,2,dipropylxanthine. Br. J. Pharmacol. 104: 1062-1068, 1991.
17. Levens, N., M. Beil, and M. Jarvis. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor. J. Pharmacol. Exp. Ther. 257: 1005-1012, 1991.
18. Lin, J.-J., P. C. Churchill, and A. K. Bidani. Effect of theophylline on the initiation phase of postischemic acute renal failure. J. Lab. Clin. Med. 108: 150-154, 1986.
19. Linas, S., D. Whittenburg, and J. E. Repine. Nitric oxide prevents neutrophil-mediated acute renal failure. Am. J. Physiol. 272 (Renal Physiol. 41): F48-F54, 1997.
20. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15: 298-306, 1994.
21. 125I]iodophenyl)ethylamino]adenosine. Mol. Pharmacol. 47: 307-313, 1995.
22. 1-receptor antagonist, against cisplatin-induced acute renal failure. Jpn. J. Pharmacol. 67: 349-357, 1995.
23. Okusa, M. D., R. J. Unwin, H. Velazquez, G. Giebisch, and F. S. Wright. Active potassium absorption by the renal distal tubule. Am. J. Physiol. 262 (Renal Fluid Electrolyte Physiol. 31): F488-F493, 1992.
24. Olah, M. E., and G. L. Stiles. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35: 581-606, 1995.
25. 2A receptors and neuroprotection. Ann. NY Acad. Sci. 825: 30-48, 1997.
26. Osswald, H., H.-J. Schmitz, and R. Kemper. Tissue content of adenosine, inosine and hypoxanthine in rat kidney after ischemia and postischemic recirculation. Pflügers Arch. 371: 45-49, 1977.
27. 2A-selective adenosine receptor antagonist. Br. J. Pharmacol. 115: 1096-1102, 1995.
28. Rabb, H., Y. M. O'Meara, P. Maderna, P. Coleman, and H. R. Brady. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 51: 1463-1468, 1997.
29. 2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure. Biochem. Pharmacol. 51: 545-555, 1996.
30. 2A receptors in the rat central nervous system. J. Comp. Neurol. 401: 163-186, 1998.
31. 2A-adenosine receptor reserve for coronary vasodilation. Circulation 98: 711-718, 1998.
32. Silldorff, E. P., M. S. Kreisberg, and T. L. Pallone. Adenosine modulates vasomotor tone in outer medullary descending vasa recta of the rat. J. Clin. Invest. 98: 18-23, 1996.
33. Spielman, W. S., and L. J. Arend. Adenosine receptors and signaling in the kidney. Hypertension 17: 117-130, 1991.
34. Sullivan, G. S. Adenosine receptors, blood vessels and inflammation. In: Cardiovascular Biology of Purines, edited by G. Burnstock, B. T. Liang, and J. Linden. Boston, MA: Kluwer Academic, 1998, p. 271-289.
35. Thadhani, R., M. Pascual, and J. V. Bonventre. Acute renal failure. N. Engl. J. Med. 334: 1448-1460, 1996.
36. 3H]-CGS 21680. Br. J. Pharmacol. 117: 1693-1701, 1996.
37. Weaver, D. R. and S. M. Reppert. Adenosine receptor gene expression in rat kidney. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F991-F995, 1992.
38. Weihprecht, H., J. N. Lorenz, J. P. Briggs, and J. Schnermann. Vasomotor effects of purinergic agonists in isolated rabbit afferent arterioles. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F1026-F1033, 1992.
39. Willinger, C. C., H. Schramek, K. Pfaller, and W. Pfaller. Tissue distribution of neutrophils in postischemic acute renal failure. Virchows Arch. [B] 62: 237-243, 1992.